NCT05124600 An Individualized-health eLibrary App for People With Multiple Sclerosis
| NCT ID | NCT05124600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Urbana-Champaign |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2021-10-25 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2021-10-25 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the effectiveness after using a new individualized-health e-library app named SavvyHealth among people with multiple sclerosis.
Eligibility Criteria
Inclusion Criteria: * diagnosed with MS; * 18 years or older; * one comorbidity evaluated by a validated comorbidity questionnaire for people with MS; * willing to take a survey; * willing to use the app for 21 days; * willing to be assigned to either the intervention or control group. Exclusion Criteria: \-
Contact & Investigator
Chungyi Chiu
PRINCIPAL INVESTIGATOR
University of Illinois at Urbana-Champaign
Frequently Asked Questions
Who can join the NCT05124600 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05124600 currently recruiting?
Yes, NCT05124600 is actively recruiting participants. Contact the research team at chiucy@illinois.edu for enrollment information.
Where is the NCT05124600 trial being conducted?
This trial is being conducted at Champaign, United States.
Who is sponsoring the NCT05124600 clinical trial?
NCT05124600 is sponsored by University of Illinois at Urbana-Champaign. The principal investigator is Chungyi Chiu at University of Illinois at Urbana-Champaign. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.